Penumbra
$235.71
24H
Market Cap
Volume
Supply
Price Chart
About Penumbra - PEN
Penumbra, Inc. is a medical device company that develops, manufactures, and markets innovative products designed to address challenging medical conditions in markets such as neuro and peripheral vascular diseases. Their portfolio commonly includes devices for stroke intervention, neurovascular therapies, and access products.
What are Penumbra's core values and mission statement?
Penumbra, Inc.'s core values center around innovation, teamwork, and patient well-being, as the company focuses on developing pioneering medical therapies. The mission statement emphasizes their commitment to challenging the status quo in healthcare by creating novel and impactful technologies to treat challenging medical conditions.
Who founded Penumbra and when?
Penumbra, Inc. was founded by Arani Bose and Adam Elsesser in 2004.
Who leads Penumbra?
As of the last update I have, Adam Elsesser is the co-founder, Chairman, and CEO of Penumbra, Inc.
Where is Penumbra located, and what is its base country?
Penumbra, Inc. is located in Alameda, California, United States, and its base country is the United States of America.
On which exchanges is Penumbra traded?
Penumbra, Inc. is traded on the New York Stock Exchange (NYSE) under the ticker symbol 'PEN'.
Historical data
Penumbra (PEN) Price Live Data
The live price of Penumbra (PEN) is $235.71, with a trading volume of 236,356 in the last 24 hours. Wrapstocks updates the PEN price in real-time. Penumbra is up 1.13% in the last 24 hours. The company has a live market cap of $9,046,361,088.00 and a supply of 38,379,199 PEN stocks.
Penumbra (PEN) is traded on New York Stock Exchange, and currently, the market is closed; trading will be resumed in 6 hours and 28 minutes.
